Dataset Information


Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia.

ABSTRACT: Serum is an abundant and accessible source of circulating extracellular vesicles (EVs). Serum-EV (sEV) pro-angiogenic capability and mechanisms are herein analyzed using an in vitro assay which predicts sEV angiogenic potential in vivo. Effective sEVs (e-sEVs) also improved vascular remodeling and prevented muscle damage in a mouse model of acute hind limb ischemia. e-sEV angiogenic proteomic and transcriptomic analyses show a positive correlation with matrix-metalloproteinase activation and extracellular matrix organization, cytokine and chemokine signaling pathways, Insulin-like Growth Factor and platelet pathways, and Vascular Endothelial Growth Factor signaling. A discrete gene signature, which highlights differences in e-sEV and ineffective-EV biological activity, was identified using gene ontology (GO) functional analysis. An enrichment of genes associated with the Transforming Growth Factor beta 1 (TGF?1) signaling cascade is associated with e-sEV administration but not with ineffective-EVs. Chromatin immunoprecipitation analysis on the inhibitor of DNA binding I (ID1) promoter region, and the knock-down of small mother against decapentaplegic (SMAD)1-5 proteins confirmed GO functional analyses. This study demonstrates sEV pro-angiogenic activity, validates a simple, sEV pro-angiogenic assay which predicts their biological activity in vivo, and identifies the TGF?1 cascade as a relevant mediator. We propose serum as a readily available source of EVs for therapeutic purposes.

SUBMITTER: Cavallari C 

PROVIDER: S-EPMC5557987 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC6971269 | BioStudies
2019-01-01 | S-EPMC6442110 | BioStudies
2020-01-01 | S-EPMC7601085 | BioStudies
2017-01-01 | S-EPMC5405565 | BioStudies
2020-01-01 | S-EPMC7520983 | BioStudies
2020-01-01 | S-EPMC7414114 | BioStudies
2020-01-01 | S-EPMC7227017 | BioStudies
2020-01-01 | S-EPMC7480578 | BioStudies
2021-01-01 | S-EPMC7797667 | BioStudies
2020-01-01 | S-EPMC7504614 | BioStudies